Citations (106)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Chuan-long Zhang, Meng-qi Gao, Xiao-chen Jiang, Xue Pan, Xi-yuan Zhang, Yi Li, Qian Shen, Yan Chen & Bo Pang. (2023) Research progress and value of albumin-related inflammatory markers in the prognosis of non-small cell lung cancer: a review of clinical evidence. Annals of Medicine 55:1, pages 1294-1307.
Read now
Read now
Kotoe Takayoshi, Keita Uchino, Masahiro Nakano, Koji Ikejiri & Eishi Baba. (2017) Weight Loss During Initial Chemotherapy Predicts Survival in Patients With Advanced Gastric Cancer. Nutrition and Cancer 69:3, pages 408-415.
Read now
Read now
Karla Sánchez-Lara, JennyG Turcott, Eva Juárez, Patricia Guevara, Carolina Núñez-Valencia, LuisF. Oñate-Ocaña, Diana Flores & Oscar Arrieta. (2012) Association of Nutrition Parameters Including Bioelectrical Impedance and Systemic Inflammatory Response With Quality of Life and Prognosis in Patients With Advanced Non-Small-Cell Lung Cancer: A Prospective Study. Nutrition and Cancer 64:4, pages 526-534.
Read now
Read now
Elizabeth B. Windgassen, Luciana Funtowicz, Tisha N. Lunsford, Lucinda A. Harris & Sharon L. Mulvagh. (2011) C-Reactive Protein and High-Sensitivity C-Reactive Protein: An Update for Clinicians. Postgraduate Medicine 123:1, pages 114-119.
Read now
Read now
Jane A. Read, S. T. Boris Choy, Philip J. Beale & Stephen J. Clarke. (2006) Evaluation of Nutritional and Inflammatory Status of Advanced Colorectal Cancer Patients and Its Correlation With Survival. Nutrition and Cancer 55:1, pages 78-85.
Read now
Read now
Elena Paillaud, Phuong-Nhi Bories, Sophie Letulle Aita, Elisabeth Scherman, Valérie Jeanfaivre, Jean-Louis Lejonc & Bernard Campillo. (2003) Prognostic Value of Dietary Intake and Inflammation on Survival in Patients With Advanced Cancer: Relationship With Performance Status, Pain, and Digestive Disorders. Nutrition and Cancer 45:1, pages 30-35.
Read now
Read now
Donald C. McMillan, Lynn M. Forrest, Patricia O'Gorman, Wilson J. Angerson & Colin S. McArdle. (2002) Performance Status of Male and Female Advanced Cancer Patients Is Independently Predicted by Mid-Upper Arm Circumference Measurement. Nutrition and Cancer 42:2, pages 191-193.
Read now
Read now
Donald C. McMillan, Walter S. Watson, Patricia O'Gorman, Tom Preston, Hazel R. Scott & Colin S. McArdle. (2001) Albumin Concentrations Are Primarily Determined by the Body Cell Mass and the Systemic Inflammatory Response in Cancer Patients With Weight Loss. Nutrition and Cancer 39:2, pages 210-213.
Read now
Read now
Articles from other publishers (98)
Tomoaki Bekki, Manabu Shimomura, Tomohiro Adachi, Masashi Miguchi, Satoshi Ikeda, Masanori Yoshimitsu, Mohei Kohyama, Masahiro Nakahara, Hironori Kobayashi, Kazuhiro Toyota, Yosuke Shimizu, Daisuke Sumitani, Yasufumi Saito, Yuji Takakura, Yasuyo Ishizaki, Shinya Kodama, Masahiko Fujimori, Minoru Hattori, Wataru Shimizu & Hideki Ohdan. (2023) Predictive factors associated with anastomotic leakage after resection of rectal cancer: a multicenter study with the Hiroshima Surgical study group of Clinical Oncology. Langenbeck's Archives of Surgery 408:1.
Crossref
Crossref
Yoshinori Fujiwara, Shunji Endo, Masaharu Higashida, Hisako Kubota, Kazuhiko Yoshimatsu & Tomio Ueno. (2022) The prognostic significance of preoperative nutritional/inflammatory markers and clinicopathological features in resectable esophagectomy patients: possibility of nutritional intervention. Esophagus 20:2, pages 234-245.
Crossref
Crossref
Antoine El Asmar, Martin Delcourt, Leonel Kamden, Charif Khaled, Ali Bohlok, Michel Moreau, Francesco Sclafani, Vincent Donckier & Gabriel Liberale. (2022) Prognostic Value of Preoperative Serological Biomarkers in Patients Undergoing Curative-Intent Cytoreductive Surgery for Colorectal Cancer Peritoneal Metastases. Annals of Surgical Oncology 30:3, pages 1863-1869.
Crossref
Crossref
Tatsuki Ikoma, Toshihiko Matsumoto, Yusuke Kurioka, Masahiro Takatani, Hiroki Nagai, Yusuke Matsumoto, Hironaga Satake & Hisateru Yasui. (2022) Improvement of Body Weight and Nutritional Status in Gastric Cancer Patients Enhances the Benefit of Nivolumab Therapy. Journal of Clinical Medicine 11:20, pages 6100.
Crossref
Crossref
Atakan Topçu & Ayşe İrem Yasin. (2022) Impact of Malnutrition on Prognosis in Patients with HER2-negative Metastatic Gastric Cancer. Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy 18:2, pages 258-265.
Crossref
Crossref
Coline Montegut, Florian Correard, Emilie Nouguerède, Dominique Rey, Thomas Chevalier, Marie Meurer, Jean-Laurent Deville, Marjorie Baciuchka, Vincent Pradel, Laurent Greillier, Patrick Villani & Anne-Laure Couderc. (2021) Prognostic Value of the B12/CRP Index in Older Systemically Treatable Cancer Patients. Cancers 14:1, pages 169.
Crossref
Crossref
Hatice Demirag, Nurşen Kulakaç, Sevilay Hintistan & Dilek Çilingir. (2021) Relationship of Cachexia with Self-Care Agency and Quality of Life in Cancer Patients: The Case of Turkey. Asia-Pacific Journal of Oncology Nursing 8:5, pages 547-554.
Crossref
Crossref
Yoshihiro Hiramatsu, Hiraku Kumamaru, Hirotoshi Kikuchi, Shiyori Usune, Kinji Kamiya, Hiroaki Miyata, Hiroyuki Konno, Yoshihiro Kakeji, Yuko Kitagawa & Hiroya Takeuchi. (2021) Significance of the Glasgow prognostic score for short‐term surgical outcomes: A nationwide survey using the Japanese National Clinical Database. Annals of Gastroenterological Surgery 5:5, pages 659-668.
Crossref
Crossref
Antoine El Asmar, Elie Ghabi, Toufic Saber, Christina Abou-Malhab, Bernard Akl & Ziad El Rassi. (2020) Platelet-to-lymphocyte ratio is correlated with a delay in feeding resumption following a transhiatal esophagectomy with cervical anastomosis. World Journal of Surgical Oncology 18:1.
Crossref
Crossref
Hasan Ersöz, İsmail Ağababaoğlu, İbrahim Taylan, Ebru Çakır, Saliha Aksun & Ensari Güneli. (2020) Do oral amino acid supplements facilitate the healing of rat lung injuries?. European Journal of Cardio-Thoracic Surgery 58:5, pages 983-990.
Crossref
Crossref
Mi-Rae Kim, A-Sol Kim, Hye-In Choi, Jae-Hun Jung, Ji Yeon Park & Hae-Jin Ko. (2020) Inflammatory markers for predicting overall survival in gastric cancer patients: A systematic review and meta-analysis. PLOS ONE 15:7, pages e0236445.
Crossref
Crossref
Dhwani T. Dave & Bhoomika M. Patel. (2020) Mitochondrial Metabolism in Cancer Cachexia: Novel Drug Target. Current Drug Metabolism 20:14, pages 1141-1153.
Crossref
Crossref
Won Sub Lim, Jong-Lyel Roh, Sung-Bae Kim, Seung-Ho Choi, Soon Yuhl Nam & Sang Yoon Kim. (2017) Pretreatment albumin level predicts survival in head and neck squamous cell carcinoma. The Laryngoscope 127:12, pages E437-E442.
Crossref
Crossref
Hirofumi Ohmura, Keita Uchino, Tatsuhiro Kajitani, Naotaka Sakamoto & Eishi Baba. (2017) Predictive value of the modified Glasgow Prognostic Score for the therapeutic effects of molecular-targeted drugs on advanced renal cell carcinoma. Molecular and Clinical Oncology 6:5, pages 669-675.
Crossref
Crossref
Victoria Louise Reid, Rachael McDonald, Amara Callistus Nwosu, Stephen R. Mason, Chris Probert, John E. Ellershaw & Séamus Coyle. (2017) A systematically structured review of biomarkers of dying in cancer patients in the last months of life; An exploration of the biology of dying. PLOS ONE 12:4, pages e0175123.
Crossref
Crossref
J. Kimura, C. Kunisaki, H. Makino, T. Oshima, M. Ota, M. Oba, R. Takagawa, T. Kosaka, H. A. Ono, H. Akiyama & I. Endo. (2016) Evaluation of the Glasgow Prognostic Score in patients receiving chemoradiotherapy for stage III and IV esophageal cancer. Diseases of the Esophagus 29:8, pages 1071-1080.
Crossref
Crossref
B. Doleman, K. T. Mills, S. Lim, M. D. Zelhart & G. Gagliardi. (2016) Body mass index and colorectal cancer prognosis: a systematic review and meta-analysis. Techniques in Coloproctology 20:8, pages 517-535.
Crossref
Crossref
Koichi Takayama, Shinji Atagi, Fumio Imamura, Hiroshi Tanaka, Koichi Minato, Toshiyuki Harada, Nobuyuki Katakami, Takuma Yokoyama, Kozo Yoshimori, Yuichi Takiguchi, Osamu Hataji, Yuichiro Takeda, Keisuke Aoe, Young Hak Kim, Soichiro Yokota, Hiroshi Tabeta, Keisuke Tomii, Yasuo Ohashi, Kenji Eguchi & Koshiro Watanabe. (2016) Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients—Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study. Supportive Care in Cancer 24:8, pages 3473-3480.
Crossref
Crossref
Koji Amano, Isseki Maeda, Tatsuya Morita, Tomofumi Miura, Satoshi Inoue, Masayuki Ikenaga, Yoshihisa Matsumoto, Mika Baba, Ryuichi Sekine, Takashi Yamaguchi, Takeshi Hirohashi, Tsukasa Tajima, Ryohei Tatara, Hiroaki Watanabe, Hiroyuki Otani, Chizuko Takigawa, Yoshinobu Matsuda, Hiroka Nagaoka, Masanori Mori & Hiroya Kinoshita. (2016) Clinical Implications of C-Reactive Protein as a Prognostic Marker in Advanced Cancer Patients in Palliative Care Settings. Journal of Pain and Symptom Management 51:5, pages 860-867.
Crossref
Crossref
Shiva Shrotriya, Declan Walsh, Nabila Bennani-Baiti, Shirley Thomas & Cliona Lorton. (2015) C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review. PLOS ONE 10:12, pages e0143080.
Crossref
Crossref
Ozgur Tanriverdi, Nilufer Avci, Esin Oktay, Serdar Kalemci, Kezban Nur Pilanci, Suna Cokmert, Serkan Menekse, Muharrem Kocar, Cenk Ahmet Sen, Tulay Akman, Cetin Ordu, Gamze Goksel, Nezih Meydan & Sabri Barutca. (2015) Pretreatment Serum Albumin Level is an Independent Prognostic Factor in Patients with Stage IIIB Non-Small Cell Lung Cancer: A Study of the Turkish Descriptive Oncological Researches Group. Asian Pacific Journal of Cancer Prevention 16:14, pages 5971-5976.
Crossref
Crossref
Maria Aparecida Coelho de Arruda Henry, Mauro Masson Lerco, Walmar Kerche de Oliveira, Anderson Roberto Guerra & Maria Aparecida Marchesan Rodrigues. (2015) The Glasgow Prognostic Score. An useful tool to predict survival in patients with advanced esophageal squamous cell carcinoma. Acta Cirurgica Brasileira 30:8, pages 580-585.
Crossref
Crossref
Saunjoo Yoon, Oliver Grundmann, Joseph Williams & Gwen Carriere. (2015) Novel Intervention With Acupuncture for Anorexia and Cachexia in Patients With Gastrointestinal Tract Cancers: A Feasibility Study. Oncology Nursing Forum 42:2, pages E102-E109.
Crossref
Crossref
Marianne Maillet, Johann Dréanic, Marion Dhooge, Olivier Mir, Catherine Brezault, François Goldwasser, Stanislas Chaussade & Romain Coriat. (2014) The predictive and prognostic value of the Glasgow Prognostic Score in metastatic colorectal carcinoma patients receiving bevacizumab. Anti-Cancer Drugs 25:10, pages 1215-1219.
Crossref
Crossref
Yoshiaki Ikuta, Hiroshi Takamori, Yasuo Sakamoto, Daisuke Hashimoto, Akira Chikamoto, Hideyuki Kuroki, Kazuya Sakata, Keita Sakamoto, Hiromitsu Hayashi, Katsunori Imai, Hidetoshi Nitta, Masahiko Hirota, Keiichiro Kanemitsu, Toru Beppu & Hideo Baba. (2013) The modified Glasgow Prognostic Score (mGPS) is a good predictor of indication for palliative bypass surgery in patients with unresectable pancreatic and biliary cancers. International Journal of Clinical Oncology 19:4, pages 629-633.
Crossref
Crossref
Si-Zeng Chen & Jian-Dong Xiao. (2013) Rosiglitazone and imidapril alone or in combination alleviate muscle and adipose depletion in a murine cancer cachexia model. Tumor Biology 35:1, pages 323-332.
Crossref
Crossref
Monica P. Parmar, Tara Swanson & R. Thomas Jagoe. (2013) Weight changes correlate with alterations in subjective physical function in advanced cancer patients referred to a specialized nutrition and rehabilitation team. Supportive Care in Cancer 21:7, pages 2049-2057.
Crossref
Crossref
Hajime Suzuki, Akihiro Asakawa, Haruka Amitani, Norifumi Nakamura & Akio Inui. (2013) Cancer cachexia—pathophysiology and management. Journal of Gastroenterology 48:5, pages 574-594.
Crossref
Crossref
Frank A. Sinicrope, Nathan R. Foster, Greg Yothers, Al Benson, Jean Francois Seitz, Roberto Labianca, Richard M. Goldberg, Aimery DeGramont, Michael J. O'Connell & Daniel J. Sargent. (2013) Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy. Cancer 119:8, pages 1528-1536.
Crossref
Crossref
Tahir Qayyum, Peter McArdle, Mustafa Hilmy, James Going, Clare Orange, Morag Seywright, Paul Horgan, Mark Underwood & Joanne Edwards. (2013) A Prospective Study of the Role of Inflammation in Bladder Cancer. Current Urology 6:4, pages 189-193.
Crossref
Crossref
Takeshi Kubota, Naoki Hiki, Souya Nunobe, Koshi Kumagai, Susumu Aikou, Ryohei Watanabe, Takeshi Sano & Toshiharu Yamaguchi. (2012) Significance of the Inflammation-Based Glasgow Prognostic Score for Short- and Long-Term Outcomes After Curative Resection of Gastric Cancer. Journal of Gastrointestinal Surgery 16:11, pages 2037-2044.
Crossref
Crossref
D Fuchs, H Jamnig, P Heininger, M Klieber, S Schroecksnadel, M Fiegl, M Hackl, H Denz & A Amann. (2012) Decline of exhaled isoprene in lung cancer patients correlates with immune activation. Journal of Breath Research 6:2, pages 027101.
Crossref
Crossref
Brian W. Cross, Timothy V. Johnson, Austin B. DeRosa, Kenneth Ogan, John G. Pattaras, Peter T. Nieh, Omer Kucuk, Wayne B. Harris & Viraj A. Master. (2012) Preoperative Erythrocyte Sedimentation Rate Independently Predicts Overall Survival in Localized Renal Cell Carcinoma following Radical Nephrectomy. International Journal of Surgical Oncology 2012, pages 1-6.
Crossref
Crossref
Egidio Del Fabbro, Akio Inui & Florian StrasserEgidio Del Fabbro, Akio Inui & Florian Strasser. 2012. Cancer Cachexia. Cancer Cachexia
7
23
.
Jun-Eul Hwang, Ha-Na Kim, Dae-Eun Kim, Hyun-Jung Choi, Sung-Hoon Jung, Hyun-Jeong Shim, Woo-Kyun Bae, Eu-Chang Hwang, Sang-Hee Cho & Ik-Joo Chung. (2011) Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer. BMC Cancer 11:1.
Crossref
Crossref
Nabila Bennani-Baiti & Declan Walsh. (2010) Animal models of the cancer anorexia–cachexia syndrome. Supportive Care in Cancer 19:9, pages 1451-1463.
Crossref
Crossref
Yogesh K. Vashist, Julian Loos, Josephine Dedow, Michael Tachezy, Guentac Uzunoglu, Asad Kutup, Emre F. Yekebas & Jakob R. Izbicki. (2010) Glasgow Prognostic Score is a Predictor of Perioperative and Long-term Outcome in Patients with only Surgically Treated Esophageal Cancer. Annals of Surgical Oncology 18:4, pages 1130-1138.
Crossref
Crossref
Chigusa Morizane, Takuji Okusaka, Satoshi Morita, Katsuaki Tanaka, Hideki Ueno, Shunsuke Kondo, Masafumi Ikeda, Kohei Nakachi & Shuichi Mitsunaga. (2011) Construction and Validation of a Prognostic Index for Patients With Metastatic Pancreatic Adenocarcinoma. Pancreas 40:3, pages 415-421.
Crossref
Crossref
Claire L. Donohoe, Aoife M. Ryan & John V. Reynolds. (2011) Cancer Cachexia: Mechanisms and Clinical Implications. Gastroenterology Research and Practice 2011, pages 1-13.
Crossref
Crossref
Louise Henry. 2010. Nutrition and Cancer. Nutrition and Cancer
45
82
.
Mitsuru Ishizuka, Hitoshi Nagata, Kazutoshi Takagi & Keiichi Kubota. (2010) Systemic Inflammatory Response Associated with Distant Metastasis of T1 or T2 Colorectal Cancer. Digestive Diseases and Sciences 55:11, pages 3181-3187.
Crossref
Crossref
Caroline O'Dowd, Laura A. McRae, Donald C. McMillan, Alan Kirk & Robert Milroy. (2010) Elevated Preoperative C-reactive Protein Predicts Poor Cancer Specific Survival in Patients Undergoing Resection for Non-small Cell Lung Cancer. Journal of Thoracic Oncology 5:7, pages 988-992.
Crossref
Crossref
A. Kutup, Y.K. Vashist, J. Loos, J. Dedow, J. Metze, F. Gebauer, E. F. Yekebas & J.R. Izbicki. 2010. Chirurgisches Forum und DGAV Forum 2010. Chirurgisches Forum und DGAV Forum 2010
93
94
.
J. Skipworth, J. Foster, D. Raptis & F. Hughes. (2009) The effect of preoperative weight loss and body mass index on postoperative outcome in patients with esophagogastric carcinoma. Diseases of the Esophagus 22:7, pages 559-563.
Crossref
Crossref
Yuji Toiyama, Chikao Miki, Yasuhiro Inoue, Yoshinaga Okugawa, Kouji Tanaka & Masato Kusunoki. (2009) Serum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patients. International Journal of Cancer 125:7, pages 1657-1662.
Crossref
Crossref
F. Bozzetti, J. Arends, K. Lundholm, A. Micklewright, G. Zurcher & M. Muscaritoli. (2009) ESPEN Guidelines on Parenteral Nutrition: Non-surgical oncology. Clinical Nutrition 28:4, pages 445-454.
Crossref
Crossref
J.K. Pine, K.G. Fusai, R. Young, D. Sharma, B.R. Davidson, K.V. Menon & S.H. Rahman. (2009) Serum C-reactive protein concentration and the prognosis of ductal adenocarcinoma of the head of pancreas. European Journal of Surgical Oncology (EJSO) 35:6, pages 605-610.
Crossref
Crossref
Sadeeka Al-MajidD. Patricia Gray. (2009) A Biobehavioral Model for the Study of Exercise Interventions in Cancer-related Fatigue. Biological Research For Nursing 10:4, pages 381-391.
Crossref
Crossref
Nabila Bennani-Baiti & Mellar P. Davis. (2008) Review Article: Cytokines and Cancer Anorexia Cachexia Syndrome. American Journal of Hospice and Palliative Medicine® 25:5, pages 407-411.
Crossref
Crossref
Gavin W.A. Lamb, Peter A. McArdle, Sara Ramsey, Anne-Marie McNichol, Joanne Edwards, Michael Aitchison & Donald C. McMillan. (2008) The relationship between the local and systemic inflammatory responses and survival in patients undergoing resection for localized renal cancer. BJU International 102:6, pages 756-761.
Crossref
Crossref
K. Canna, M. Hilmy, D. C. McMillan, G. W. Smith, R. F. McKee, C. S. McArdle & A.-M. McNicol. (2008) The relationship between tumour proliferative activity, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer. Colorectal Disease 10:7, pages 663-667.
Crossref
Crossref
Eleni M. Karapanagiotou, Emmanouil A. Tsochatzis, Kalliopi D. Dilana, Ioannis Tourkantonis, Ioannis Gratsias & Konstantinos N. Syrigos. (2008) The significance of leptin, adiponectin, and resistin serum levels in non-small cell lung cancer (NSCLC). Lung Cancer 61:3, pages 391-397.
Crossref
Crossref
Andrew B C Crumley, Robert C Stuart, Margaret McKernan, Alexander C McDonald & Donald C McMillan. (2008) Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG-ps) in patients receiving palliative chemotherapy for gastroesophageal cancer. Journal of Gastroenterology and Hepatology 23:8pt2, pages e325-e329.
Crossref
Crossref
Donald C. McMillan. (2008) An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proceedings of the Nutrition Society 67:3, pages 257-262.
Crossref
Crossref
Trinitia Cannon, Carol Shores, Xiaoying Yin, Jason Dahlman, Denis Guttridge, Victor Lai, Jonathan George, Petra Buzkova & Marion Couch. (2007) Immunocompetent murine model of cancer cachexia for head and neck squamous cell carcinoma. Head & Neck 30:3, pages 320-326.
Crossref
Crossref
Joseph EM Crozier, Donald C McMillan, Colin S McArdle, Wilson J Angerson, John H Anderson, Paul G Horgan & Ruth F McKee. (2007) Tumor size is associated with the systemic inflammatory response but not survival in patients with primary operable colorectal cancer. Journal of Gastroenterology and Hepatology 22:12, pages 2288-2291.
Crossref
Crossref
Mitsuru Ishizuka, Hitoshi Nagata, Kazutoshi Takagi, Toru Horie & Keiichi Kubota. (2007) Inflammation-Based Prognostic Score Is a Novel Predictor of Postoperative Outcome in Patients With Colorectal Cancer. Annals of Surgery 246:6, pages 1047-1051.
Crossref
Crossref
Aoife M. Ryan, Laura A. Healy, Derek G. Power, Suzanne P. Rowley & John V. Reynolds. (2007) Short-term nutritional implications of total gastrectomy for malignancy, and the impact of parenteral nutritional support. Clinical Nutrition 26:6, pages 718-727.
Crossref
Crossref
L Kelly, S White & P.C. Stone. (2007) The B12/CRP index as a simple prognostic indicator in patients with advanced cancer: a confirmatory study. Annals of Oncology 18:8, pages 1395-1399.
Crossref
Crossref
J E M Crozier, R F McKee, C S McArdle, W J Angerson, J H Anderson, P G Horgan & D C McMillan. (2007) Preoperative but not postoperative systemic inflammatory response correlates with survival in colorectal cancer. British Journal of Surgery 94:8, pages 1028-1032.
Crossref
Crossref
Sang-Yeon Suh & Hong-Yup Ahn. (2007) A prospective study on C-reactive protein as a prognostic factor for survival time of terminally ill cancer patients. Supportive Care in Cancer 15:6.
Crossref
Crossref
A M Al Murri, C Wilson, A Lannigan, J C Doughty, W J Angerson, C S McArdle & D C McMillan. (2007) Evaluation of the relationship between the systemic inflammatory response and cancer-specific survival in patients with primary operable breast cancer. British Journal of Cancer 96:6, pages 891-895.
Crossref
Crossref
Michael Michael, David Goldstein, Stephen J. Clarke, Alvin D. Milner, Phillip Beale, Michael Friedlander & Paul Mitchell. (2006) Prognostic Factors Predictive of Response and Survival to a Modified FOLFOX Regimen: Importance of an Increased Neutrophil Count. Clinical Colorectal Cancer 6:4, pages 297-304.
Crossref
Crossref
M Hilmy, R Campbell, J M S Bartlett, A-M McNicol, M A Underwood & D C McMillan. (2006) The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic infiltration and COX-2 expression and survival in patients with transitional cell carcinoma of the urinary bladder. British Journal of Cancer 95:9, pages 1234-1238.
Crossref
Crossref
S Ramsey, G W A Lamb, M Aitchison & D C McMillan. (2006) The longitudinal relationship between circulating concentrations of C-reactive protein, interleukin-6 and interleukin-10 in patients undergoing resection for renal cancer. British Journal of Cancer 95:8, pages 1076-1080.
Crossref
Crossref
Catherine A. Hauser, Martin R. Stockler & Martin H. N. Tattersall. (2006) Prognostic factors in patients with recently diagnosed incurable cancer: a systematic review. Supportive Care in Cancer 14:10, pages 999-1011.
Crossref
Crossref
J E M Crozier, R F McKee, C S McArdle, W J Angerson, J H Anderson, P G Horgan & D C McMillan. (2006) The presence of a systemic inflammatory response predicts poorer survival in patients receiving adjuvant 5-FU chemotherapy following potentially curative resection for colorectal cancer. British Journal of Cancer 94:12, pages 1833-1836.
Crossref
Crossref
A B C Crumley, D C McMillan, M McKernan, J J Going, C J Shearer & R C Stuart. (2006) An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer. British Journal of Cancer 94:11, pages 1568-1571.
Crossref
Crossref
J. Arends, G. Bodoky, F. Bozzetti, K. Fearon, M. Muscaritoli, G. Selga, M.A.E. van Bokhorst-de van der Schueren, M. von Meyenfeldt, G. Zürcher, R. Fietkau, E. Aulbert, B. Frick, M. Holm, M. Kneba, H.J. Mestrom & A. Zander. (2006) ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology. Clinical Nutrition 25:2, pages 245-259.
Crossref
Crossref
G W A Lamb, D C McMillan, S Ramsey & M Aitchison. (2006) The relationship between the preoperative systemic inflammatory response and cancer-specific survival in patients undergoing potentially curative resection for renal clear cell cancer. British Journal of Cancer 94:6, pages 781-784.
Crossref
Crossref
A B C Crumley, D C McMillan, M McKernan, A C McDonald & R C Stuart. (2006) Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer. British Journal of Cancer 94:5, pages 637-641.
Crossref
Crossref
A M Al Murri, J M S Bartlett, P A Canney, J C Doughty, C Wilson & D C McMillan. (2006) Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer. British Journal of Cancer 94:2, pages 227-230.
Crossref
Crossref
Max Dahele & Kenneth C. H. Fearon. 2006. Cachexia and Wasting: A Modern Approach. Cachexia and Wasting: A Modern Approach
125
135
.
K Fearon, M Dahele & R Skipworth. 2005. Pharmacotherapy of Cachexia. Pharmacotherapy of Cachexia
117
142
.
Sara Ramsey & Michael Aitchison. (2005) RE: C-REACTIVE PROTEIN: A BIOMARKER OF SURVIVAL IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH SUBCUTANEOUS INTERLEUKIN-2 BASED IMMUNOTHERAPY. Journal of Urology 174:6, pages 2422-2423.
Crossref
Crossref
L M Forrest, D C McMillan, C S McArdle, W J Angerson, K Dagg & H R Scott. (2005) A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer. British Journal of Cancer 92:10, pages 1834-1836.
Crossref
Crossref
K Canna, P A McArdle, D C McMillan, A-M McNicol, G W Smith, R F McKee & C S McArdle. (2005) The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer. British Journal of Cancer 92:4, pages 651-654.
Crossref
Crossref
M Hilmy, J M S Bartlett, M A Underwood & D C McMillan. (2005) The relationship between the systemic inflammatory response and survival in patients with transitional cell carcinoma of the urinary bladder. British Journal of Cancer 92:4, pages 625-627.
Crossref
Crossref
Erin Graves, Andrew Hitt, Michael W. Pariza, Mark E. Cook & Donna O. McCarthy. (2004) Conjugated linoleic acid preserves gastrocnemius muscle mass in mice bearing the colon‐26 adenocarcinoma. Research in Nursing & Health 28:1, pages 48-55.
Crossref
Crossref
Jun Tian. (2005) Nutritional status and quality of life of the gastric cancer patients in Changle County of China. World Journal of Gastroenterology 11:11, pages 1582.
Crossref
Crossref
N B Jamieson, P Glen, D C McMillan, C J McKay, A K Foulis, R Carter & C W Imrie. (2004) Systemic inflammatory response predicts outcome in patients undergoing resection for ductal adenocarcinoma head of pancreas. British Journal of Cancer 92:1, pages 21-23.
Crossref
Crossref
E Bromwich, D C McMillan, G W A Lamb, P A Vasey & M Aitchison. (2004) The systemic inflammatory response, performance status and survival in patients undergoing alpha-interferon treatment for advanced renal cancer. British Journal of Cancer 91:7, pages 1236-1238.
Crossref
Crossref
Max Dahele & Kch Fearon. (2016) Research methodology: cancer cachexia syndrome. Palliative Medicine 18:5, pages 409-417.
Crossref
Crossref
R Al-Shaiba, D C McMillan, W J Angerson, E Leen, C S McArdle & P Horgan. (2004) The relationship between hypoalbuminaemia, tumour volume and the systemic inflammatory response in patients with colorectal liver metastases. British Journal of Cancer 91:2, pages 205-207.
Crossref
Crossref
Nigel B Jamieson, Duncan J.F Brown, A Michael Wallace & Donald C McMillan. (2004) Adiponectin and the systemic inflammatory response in weight-losing patients with non-small cell lung cancer. Cytokine 27:2-3, pages 90-92.
Crossref
Crossref
Jeanne M. Wallace. (2016) Integrative Tumor Board: Glioblastoma Multiforme. Integrative Cancer Therapies 3:2, pages 152-163.
Crossref
Crossref
Donna O. McCarthy, Pamela Whitney, Andrew Hitt & Sadeeka Al‐Majid. (2004) Indomethacin and ibuprofen preserve gastrocnemius muscle mass in mice bearing the colon‐26 adenocarcinoma. Research in Nursing & Health 27:3, pages 174-184.
Crossref
Crossref
L M Forrest, D C McMillan, C S McArdle, W J Angerson & D J Dunlop. (2004) Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer. British Journal of Cancer 90:9, pages 1704-1706.
Crossref
Crossref
K Canna, D C McMillan, R F McKee, A-M McNicol, P G Horgan & C S McArdle. (2004) Evaluation of a cumulative prognostic score based on the systemic inflammatory response in patients undergoing potentially curative surgery for colorectal cancer. British Journal of Cancer 90:9, pages 1707-1709.
Crossref
Crossref
Richard A Krasuski, Anneke Bush, Joseph E Kay, Charles E MayesJrJr, Andrew Wang, Judy Fleming, Cynthia Pierce, Katherine B Kisslo, J.Kevin Harrison & Thomas M Bashore. (2003) C-reactive protein elevation independently influences the procedural success of percutaneous balloon mitral valve commissurotomy. American Heart Journal 146:6, pages 1099-1104.
Crossref
Crossref
L M Forrest, D C McMillan, C S McArdle, W J Angerson & D J Dunlop. (2003) Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. British Journal of Cancer 89:6, pages 1028-1030.
Crossref
Crossref
Donna O. McCarthy. (2016) Rethinking Nutritional Support for Persons with Cancer Cachexia. Biological Research For Nursing 5:1, pages 3-17.
Crossref
Crossref
F.J.F. Engelken, V. Bettschart, M.Q. Rahman, R.W. Parks & O.J. Garden. (2003) Prognostic factors in the palliation of pancreatic cancer. European Journal of Surgical Oncology (EJSO) 29:4, pages 368-373.
Crossref
Crossref
Shin-ichi Ikuta, Chikao Miki, Koji Tanaka, Naomi Konishi, Yasuhiko Mohri, Hitoshi Tonouchi & Masato Kusunoki. (2003) Serum Immunosuppressive Acidic Protein as an Interleukin-6 Related Index of Deteriorating Condition in Gastric Cancer Patients. Digestive Surgery 20:6, pages 532-538.
Crossref
Crossref
H R Scott, D C McMillan, L M Forrest, D J F Brown, C S McArdle & R Milroy. (2002) The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer. British Journal of Cancer 87:3, pages 264-267.
Crossref
Crossref
Fade Aziz Mahmoud & Nilo I. Rivera. (2002) The role of C-reactive protein as a prognostic indicator in advanced cancer. Current Oncology Reports 4:3, pages 250-255.
Crossref
Crossref
Jeanne M. Wallace. (2016) Nutritional and Botanical Modulation of the Inflammatory Cascade—Eicosanoids, Cyclooxygenases, and Lipoxygenases— As an Adjunct in Cancer Therapy. Integrative Cancer Therapies 1:1, pages 7-37.
Crossref
Crossref
Donald McMillan, Maqsood Elahi, Naveed Sattar, Wilson Angerson, Jennie Johnstone & Colin McArdle. (2001) Measurement of the Systemic Inflammatory Response Predicts Cancer-Specific and Non-Cancer Survival in Patients With Cancer. Nutrition and Cancer 41:1, pages 64-69.
Crossref
Crossref